ALLERTEC UKASZENIA

This brand name is authorized in Poland

Active ingredients

The drug ALLERTEC UKASZENIA contains a combination of these active pharmaceutical ingredients (APIs):

1 Antazoline UNII 6T74I07212 - ANTAZOLINE SULFATE

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Read about Antazoline

2 Naphazoline UNII SC99GR1T5S - NAPHAZOLINE NITRATE

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity. Read about Naphazoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D04AA	Antihistamines for topical use	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc.
Discover more medicines within D04AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100108119